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Abstract—Whole cells from the Brazilian beans feijão da corda (Vigna unguiculata) have been employed as biocatalyst in different 
bioreduction processes. Good to excellent selectivities can be obtained in the reduction of aromatic and aliphatic ketones, as well as β-
ketoesters, depending the conversions and the chemoselectivity on the substrate structure. This biocatalyst was also able to reduce the nitro 
moiety of different aromatic nitro compounds, presenting also enoate reductase activity, chemoselectively catalyzing the double bond 
reduction of 4-phenyl-3-buten-2-one with moderate conversion. © 2016 Elsevier Science. All rights reserved 
1. Introduction 
Nowadays the preparation of enantioenriched secondary 
alcohols presents an increasing interest due to their 
numerous applications as chiral building blocks in 
pharmaceutical or (agro)chemical industry and their 
activity as pheromones and flavor or aroma enhancing 
compounds.
1
 Different methodologies have been developed 
in order to synthesize these important compounds,
2
 being 
the stereoselective reduction of ketones one of the most 
widely employed methods, since it allows the obtaining of 
these derivatives in quantitative yields.
3
 In the last few 
years, biocatalysis has emerged as a reliable alternative to 
conventional chemical methods due to the high selectivities 
achieved while employing mild, economically viable and 
eco-compatible conditions.
4
 Optically active sec-alcohols 
can be obtained employing a variety of biocatalytic 
methods
5
 involving, i.e. lipase-catalyzed kinetic 
resolutions, but in the last few years the synthesis of 
enantiopure secondary alcohols through reduction of 
ketones or oxidative kinetic resolutions of racemic alcohols 
using alcohol dehydrogenases (ADHs) has gained 
increasing interest.
6
  
On the other hand, the selective reduction of aromatic nitro 
compounds is a useful transformation applied to the 
synthesis of amines, important intermediates in the 
production of pharmaceuticals and other high added value 
derivatives.
1b,7
 This reaction also presents interest in 
bioremediation processes. For example, nitrophenols are 
widely used as industrial internediate compounds, but they 
are environmental pollutants due to their toxicity and 
resistance to biodegradation. Several methodologies have 
been described to perform the chemical reduction of nitro 
derivatives.
8
 Enzymatically, examples of this process have 
been reported employing nitroreductases whereas other 
authors have described the use of flavoenzymes for the 
hydrogenation of dinitro compounds.
9 
Plants have been considered as enzymatic systems suitable 
for being employed in biocatalysis. Most of the reactions 
catalyzed by plants are redox processes (reduction of 
aldehydes and ketones, oxidation of racemic alcohols), but 
they are also able to catalyze hydrolyses of esters and 
acylations of alcohols.
10
 Immobilized plant cell cultures as 
well as whole cell tissues present the advantages of wide 
availability at low costs, mild reaction conditions and easy 
removal after use.  
In some previous studies performed by our research groups, 
several biocatalytic systems obtained from the Brazilian 
biodiversity have been analyzed and employed in the 
reduction of prochiral ketones and the acylation of racemic 
alcohols.
11
 Herein, we describe the use of whole cells of 
Vigna unguiculata as biocatalyst in different organic 
synthetic reactions. The so-called feijão de corda or feijão 
caupi belongs to the Phaseoleae family and grows 
predominantly in the North and Northeast of Brazil, due to 
its resistance to high temperatures and water stress. This 
legume presents high interest in the Brazilian diet, since it 
is an important source of proteins (23-25% on average) and 
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carbohydrates with high contents of fiber, vitamins and 
minerals. In the present manuscript we will show that this 
preparation is able to reduce carbonyl, nitro and alkene 
compounds, demonstrating its potential as catalyst in 
organic synthesis. 
2. Results and discussion 
Our initial efforts were devoted to employ cells of Vigna 
unguiculata as biocatalyst in the reduction of a group of 
aromatic ketones. Acetophenone (1a) was chosen as model 
substrate for the optimization of the reaction conditions. A 
first set of bioreductions were performed at 30ºC during 72 
h in order to determine the best reaction medium for this 
process as shown in Table 1 (entries 1-4). When the 
bioreduction was performed in water, a 34% of the Prelog 
alcohol (S)-1b was obtained with 92% ee (entry 1). The use 
of a Tris-HCl buffer at pH 7.5 led to a slight decrease in the 
enzymatic activity (entry 2). Then, we decided to test some 
cosolvents when water was employed. The addition of 2% 
v v
-1
 
i
PrOH allowed the obtaining of enantiopure (S)-1b 
with a 35% conversion (entry 3). When DMSO was 
employed in the same amount (entry 4), the optical purity 
of the resulting alcohol was lower, while no appreciable 
change was observed in the biocatalyst activity.  
Table 1. Vigna unguiculata biocatalyzed reduction of 1a to (S)-1b in 
aqueous media at different reaction conditions.a 
O Vigna unguiculata
Reaction medium
T (ºC)/ 250 rpm
72 h
OH
1a (S)-1b  
Entry % Cosolvent T (ºC) c (%)
b ee (%)b 
1 None 30 34 92 
2c None 30 31 92 
3 2% iPrOH 30 35 ≥99 
4 2% DMSO 30 33 96 
5 5% iPrOH 30 32 ≥99 
6 10% iPrOH 30 24 ≥99 
7 30% iPrOH 30 ≤3 n.d. 
8 2% iPrOH 20 35 ≥99 
9 2% iPrOH 37 28 ≥99 
10 2% iPrOH 45 19 98 
a Reaction time, 72 h. For other reaction conditions see the Experimental 
Section. 
b Conversions (c) and enantiomeric excesses (ee) were determined by 
HPLC or GC. 
c Reaction performed using a Tris-HCl 50 mM buffer (pH 7.5). 
n.d. not determined. 
Once water containing 
i
PrOH was selected as the best 
reaction medium for the biotransformations, we analyzed 
the effect of this cosolvent on the biocatalytic properties of 
V. unguiculata. Bioreductions of 1a were carried out 
employing different concentrations of 
i
PrOH, as shown in 
entries 5-7. The use of 5% v v
-1
 
i
PrOH did not alter the 
properties of the enzyme, obtaining enantiopure (S)-1b with 
32% conversion (entry 5). Higher cosolvent concentrations 
led to a progressive deactivation of the biocatalyst, as 
indicated in entries 6 and 7. This effect was especially 
dramatic when adding 30% v v
-1
 
i
PrOH, since no reduction 
was observed in these conditions. Temperature was also 
analyzed as a key parameter in the acetophenone 
bioreduction (entries 8-10). When it was carried out at 
20ºC, the same activity and selectivity was achieved than 
working at 30ºC (entry 8). The increase of the temperature 
to 37ºC (entry 9), led to a slight deactivation of the 
biocatalyst, while at 45ºC (entry 10) the loss of the activity 
was higher (c=19%), not observing significant changes in 
the optical purity of (S)-1b. 
Table 2. Bioreductions of substituted acetophenones catalyzed by whole 
cells of Vigna unguiculata (t=72 h).a 
O
R1
V. unguiculata
H2O/ 2%
iPrOH
30ºC/ 250 rpm
72 h
OH
R1
2-12a
(S)-2-8b
(R)-9-12b
XX
 
Entry Ketone X R
1 (%) 2-12bb ee (%)b 
1 2a 4’-MeO H 5 ≥99 (S) 
2 3a 3’-MeO H 86 ≥99 (S) 
3 4a 2’-MeO H 5 ≥99 (S) 
4 5a 4’-Me H 13 96 (S) 
5 6a 2’-Me H 11 ≥99 (S) 
6 7a 4’-iPr H 13 87 (S) 
7 8a 4’-Cl H 24 ≥99 (S) 
8 9a 3’-Br H 56 ≥99 (R) 
9 10ac 4’-Cl Cl 69 ≥99 (R) 
10 11ac 2’,4’-Cl Cl 78 ≥99 (R) 
11 12ac 3’,4’-Cl Cl 78 89 (R) 
a For more detailed reaction conditions, see the Experimental Section. 
b Conversions (c) and enantiomeric excesses (ee) were determined by 
HPLC or GC. Absolute configuration of the alcohol is in brackets. 
c Absolute configuration is reversed due to a change in the substituent 
priority according to the CIP sequence rules. 
After establishing the best reaction conditions for the 
bioreduction of 1a, we extended our study to other 
acetophenone derivatives, as indicated in Table 2. For most 
of the ketones studied, the expected Prelog product was 
formed, with the exception of substrate 9a (3’-bromo), 
where the anti-Prelog alcohol (R configuration) was 
obtained, indicating that probably for this compound 
different alcohol dehydrogenase(s) were acting in the 
enzymatic system. Firstly, we analyzed the effect of an 
electron-donating group such as methoxy, observing that 
the position of this moiety greatly affected the enzymatic 
activity. While the 4’- and 2’-methoxy derivatives (2a and 
4a, respectively), showed very low conversions after 72 h 
(entries 1 and 3), (S)-3b could be obtained in an 86% extent 
(entry 2). In all these processes, alcohols were isolated in 
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enantiopure form. Substituted acetophenones with an alkyl 
group in the aromatic ring were also reduced although in a 
lower extent. While ketones 5a and 6a were reduced with 
conversions close to 13% to the corresponding enantiopure 
S-alcohols (entries 4 and 5), 4’-isopropylacetophenone 7a 
led to (S)-7b with the same conversion but lower optical 
purity (ee=87%), indicating that the presence of bulkier 
alkyl chains had a negative effect in the biocatalyst 
selectivity (entry 6). Halogenated ketones were also tested 
obtaining better results. Thus, 4’-chloroacetophenone was 
converted to (S)-8b with excellent enantiomeric excess and 
24% conversion after 72 h (entry 7). The bromo derivative 
9a (entry 8) led to the opposite enantiopure (R)-9b with 
good conversion (c=56%).  
A set of α-chloro ketones was also tested as possible 
substrates for the enzymatic processes. Reduction of these 
compounds lead to the formation of the corresponding 
halohydrins, versatile intermediates in the preparation of 
bioactive compounds.
12
 When 2-chloroacetophenone 10a 
was reduced in the presence of V. unguiculata (entry 9), the 
Prelog alcohol (R)-10b was obtained with good yield and 
excellent selectivity. The 2,2’,4’-trichloro derivative 11a 
(entry 10) also led to enantiopure (R)-11b with high 
conversion (c=78%), while bioreduction of ketone 12a 
(entry 11) occurred with the same yield, but with a lower 
selectivity [(R)-12b was obtained with ee=89%].  
Table 3. Bioreduction of aliphatic ketones and β-ketoesters employing 
Vigna unguiculata as biocatalyst.a 
R1
R2
O
30ºC/ 250 rpm
R1
R2
OH
13-16a (S)-13-15b
(R)-16b
13a R1=-CH2(CH2)4CH3 R2=H
14a R1=-CH2(CH2)7CH3 R2=H
15a R1=-CH2COOCH3 R2=H
16a R1=-CH2COOCH3 R2=Cl
Vigna unguiculata
H2O/2%
iPrOH
 
Entry Substrate t (h) c (%)b ee (%)b 
1 13a 72 16 ≥99 (S) 
2 14a 72 19 ≥99 (S) 
3 15a 48 83 ≥99 (S) 
4c 16a 48 88 ≥99 (R) 
a For reaction details, see the Experimental Section. 
b Conversion (c) and enantiomeric excesses (ee) were determined by 
HPLC or GC. Absolute configuration of the alcohol is in brackets. 
c Absolute configuration is reversed due to a change in the substituent 
priority according to the CIP sequence rules. 
 
Aliphatic ketones and β-ketoesters were also tested as 
suitable substrates for V. unguiculata (Table 3). 
Bioreduction of 2-octanone (13a) led to the formation of 
enantiopure (S)-13b with low conversion (c=16%) after 72 
h (entry 1). Enantiopure (S)-2-undecanol (14b) could be 
obtained with a slightly higher conversion at the same 
reaction time, as shown in entry 2. Whole cells were tested 
in the reduction of β-ketoesters which led to the 
corresponding chiral β-hydroxyesters, important synthons 
in organic chemistry.
13
 Ethyl acetoacetate (15a) was 
reduced with high conversion (c=83% after 48 hours, entry 
3) leading to enantiopure (S)-15b, indicating that V. 
unguiculata showed a high activity for this compound 
(complete conversion was achieved after 72 h). A similar 
result was obtained in the bioreduction of 16a (entry 4). 
After 48 h, 88% of (R)-16b with 99% ee was obtained. This 
alcohol is a useful chiral building block for the synthesis of 
different pharmaceuticals.
14
 
V. unguiculata cells were tested in the reduction of 
acetophenones presenting in their structure a nitro 
substituent in the aromatic ring, group also sensitive in 
reduction processes, in order to analyze the 
chemoselectivity of these reactions (Table 4). Thus, 
bioreduction of 4’-nitroacetophenone (17a) led after 72 h to 
the formation of two different products: the expected 
enantiopure nitro alcohol (R)-17b with 42% conversion, but 
also the amino ketone obtained from the reduction of the 
nitro group (17c), was achieved in a 54% extent (entry 1). 
Thus, this biocatalytic system presented enzyme(s) able to 
reduce the nitro moiety into the corresponding amine. 
Bioreduction of 3’-nitroacetophenone (18a) occurred with 
low conversion compared to the 4’-nitro derivative (entry 
2). Only 14% of enantiopure (S)-18b was achieved, while 
3’-aminoacetophenone (18c) was formed in an 8% extent. 
Lower activity was measured for the 2’-nitro derivative 19a 
(entry 3), leading to 4% of enantiopure (S)-19b and 8% of 
19c. This fact was probably due to sterical hindrance. No 
amino alcohol compounds were detected in any case. It is 
important to notice that the 4’-nitro derivative was reduced 
to the anti-Prelog alcohol (R)-17b, presenting the same 
behavior as substrate 9a.  
Table 4. Bioreductions of nitroacetophenones catalyzed by Vigna 
unguiculata (t=72 h).a 
O V. unguiculata
H2O/2%
iPrOH
30ºC/ 250 rpm
72 h
OH
17-19a
(R)-17b
(S)-18-19b
O
17-19c
H2N
+
O2NO2N
17a 4'-NO2
18a 3'-NO2
19a 2'-NO2
*
 
Entry Ketone (%) 17-19bb ee (%)b (%) 17-19cb 
1 17a 42 ≥99 (R) 54 
2 18a 14 ≥99 (S) 8 
3 19a 4 ≥99 (S) 8 
a For reaction conditions, see Experimental Section. 
b Conversions (c) and enantiomeric excesses (ee) were calculated by 
HPLC or GC. 
Since we found the unusual nitro reductive activity when 
reducing nitro ketones 17-19a using whole cells of V. 
unguiculata to obtain the corresponding amines, we 
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decided to test different aromatic nitro compounds as 
potential substrates for our biocatalytic system (Scheme 1). 
When nitrobenzene (20a) was treated in the presence of 
whole cells of V. unguiculata, it was possible to obtain 16% 
of aniline (20c) after 72 h. We analyzed 4- (21a) and 2-
nitrophenol (22a) as substrates, but no reaction was 
observed even after long reaction times, showing that 
electron-donor substituents disfavored this 
biotransformation. This fact could explain why amino 
alcohols were not obtained with nitro ketones 17-19a. 4-
Nitrophenyl acetate (23a) was also studied, leading after 72 
h to the complete formation (c≥99%) of the hydrolyzed 
product 4-nitrophenol (21a). When we carried out the blank 
reaction in the absence of biocatalyst, only 36% of 23a was 
hydrolyzed, indicating that V. unguiculata was also able to 
perform the acetate hydrolysis with moderate rate. 
Benzonitrile (24a) was finally employed, but the whole 
cells were not able to hydrolyze the nitrile moiety. 
NO2
V. unguiculata
H2O/2%
iPrOH
30ºC/ 250 rpm
72 h
NH2
NO2
O
O
V. unguiculata
H2O/2%
iPrOH
30ºC/ 250 rpm
72 h
NO2
HO
23a 21a
20a 20c
 
Scheme 1. V. unguiculata-catalyzed processes using nitro compounds 20a 
and 23a as substrates in aqueous media containing 2% v v-1 iPrOH. 
Asymmetric alkene reduction is an attractive reaction for 
organic chemists, as it offers the possibility of creating two 
adjacent sp
3
 centers in a single step. Enoate reductases, 
members of the “old yellow family”, catalyze this 
transformation in nature.
15
 These enzymes are widely found 
in microorganisms and plants. By this reason, we have 
started a preliminary study on this activity employing 4-
phenyl-3-buten-2-one 25a as model substrate in order to 
determine the ability of V. unguiculata to reduce double 
bonds (Scheme 2). After 72 h, a 41% of 4-phenylbutan-2-
one (25b) was obtained while only traces (less than 3%) of 
the other possible reduction products, 4-phenyl-3-buten-2-
ol (25c) and 4-phenylbutan-2-ol (25d), were observed in 
the reaction media, showing that this activity was present in 
our preparation.  
O V. unguiculata
H2O/ 2%
iPrOH
30ºC/ 250 rpm
72 h
25a
O
25b (41%)
OH
OH
25c (<3%)
25d (<3%)  
Scheme 2. Bioreduction of 4-phenyl-3-buten-2-one 25a catalyzed by 
whole cells of V. unguiculata in aqueous media containing 2% v v-1 
iPrOH. 
3. Conclusions 
We have presented Vigna unguiculata as an excellent 
stereo- and chemoselective biocatalyst for the production of 
interesting organic compounds. Whole cells from this 
vegetal source have been employed as biocatalytic system 
applied to different reduction processes. After optimizing 
the reaction conditions, i.e. the amount of cosolvent and the 
temperature using acetophenone as model substrate, this 
biocatalyst has shown a remarkable ability to reduce 
acetophenone derivatives with high to excellent 
stereoselectivites depending on the substrate structure. In 
most of the cases, the Prelog reduction products were 
obtained. Enantiopure (R)-β-chloroalcohols, interesting 
chiral synthons, could be achieved with good conversions. 
Aliphatic ketones were also reduced with total selectivity, 
while the bioreduction of β-ketoesters led to the formation 
of the corresponding enantiopure Prelog β-hydroxyesters 
with excellent conversions. Furthermore, Vigna 
unguiculata was able to reduce nitro groups to the 
corresponding amines when, e.g. nitrobenzene and 
nitroacetophenones were employed as substrates, while no 
reaction was observed in the case of nitrophenols. Whole 
cells of V. unguiculata contained at least one enoate 
reductase, as this system was able to catalyze preferentially 
the reduction of the double bond of 4-phenyl-3-buten-2-one 
with regards to the alcohol formation.  
4. Experimental  
4.1. General 
Chemical reactions were monitored by analytical TLC, 
performed on Merck silica gel 60 F254 plates and 
visualized by UV irradiation. Flash chromatography was 
carried out with silica gel 60 (230-240 mesh, Merck). IR 
spectra were recorded on a Perkin-Elmer 1720-X infrared 
Fourier transform spectrophotometer using KBr pellets. UV 
spectra were performed on a Perkin Elmer Lambda Bio10 
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UV/Vis Spectrophotometer. 
1
H-NMR, 
13
C-NMR and DEPT 
spectra were recorded with tetramethylsilane (TMS) as the 
internal standard with a Bruker AC-300 DPX (
1
H: 300.13 
MHz; 
13
C: 75.5 MHz) spectrometer. APCI
+
 and ESI
+
 using 
a Hewlett Packard 1100 chromatograph mass detector or 
EI
+
 with a Hewlett Packard 5973 mass spectrometer were 
used to record mass spectra (MS). GC analyses were 
performed on a Hewlett Packard 6890 Series II 
chromatograph equipped with a Restek RtDEXse (30 m x 
0.25 mm x 0.25 m, 1 bar N2) or a Varian CP-Chiralsil-
DEX CB (25 m x 0.32 mm x 0.25 m, 1 bar N2) for chiral 
determinations or a HP-1 (crosslinked methyl siloxane, 30 
m x 0.25 mm x 0.25 µm, 1.0 bar N2) from Hewlett-Packard 
for measuring the conversions values. For all the analyses, 
the injector temperature is 225ºC and the FID temperature 
is 250ºC. HPLC analyses were developed with a Hewlett 
Packard 1100 LC liquid chromatograph equipped with 
Chiralcel OB-H (0.46 cm x 25 cm), a Chiralpak IA (0.46 
cm x 25 cm) or a Chiralpak AS (0.46 cm x 25 cm) chiral 
columns purchased from Daicel. 
Ketones 1-4a, 6a, 8-9a, 13-18a, 25a-b, alcohol 25d, nitro 
compounds 20-23a, aromatic amines 20-22c, and 
benzonitrile 24a were products from Sigma-Aldrich, while 
compounds 5a, 7a, 10-12a and 19a were purchased from 
Alfa Aesar. All other reagents and solvents were of the 
highest quality from Sigma-Aldrich-Fluka. All the racemic 
alcohols (±)-1-19b and 25d were prepared by chemical 
reduction of the corresponding ketones employing NaBH4 
in dry methanol at room temperature. In all cases, high 
yields were achieved (higher than 80%). When necessary, 
in order to measure the enantiomeric excesses, alcohols 
were acetylated with acetic anhydride and Et3N in CH2Cl2 
to obtain the corresponding racemic acetates, being isolated 
in quantitative yields in all cases. 4-Phenyl-3-buten-2-ol 
25c was prepared following the procedure described in the 
literature, treating ketone 25a with NaBH4 in a mixture 
MeOH-THF 1:10.
16
 Aminoketones 17-19c were 
synthesized by reducing the corresponding nitroketones 17-
19a with Sn in water containing concentrated HCl and 
subsequent treatment with an aqueous solution of NaOH 
(yields from 60 to 74%).
17 
Absolute configurations of alcohols (S)-1-8b, (S)-13-15b, 
(S)-18-19b, (R)-9-12b and (R)-16-17b obtained from the V. 
unguiculata-catalyzed reductions were established by 
comparison of the retention times on GC with previously 
published data.
11a,11c,18 
4.2. Plant material 
V. unguiculata beans were collected at the planting in rural 
upstate (Miraíma, CE, Brazil). Bean seeds were rinsed with 
5% aqueous solution of sodium hypochlorite and distilled 
water and dried completely at room temperature. After that, 
beans were grinded in order to obtain a fine powder that 
was used as biocatalyst. 
4.3. General procedure for the V. unguiculata 
biocatalyzed reductions of ketones 1-19a and 25a, nitro 
derivatives 20-23a and benzonitrile 24a. 
In a typical experiment, the substrate 1-25a (5.0 mg) was 
added to a suspension of V. unguiculata powder (1.0 g) in 
3.0 mL of distilled water containing 2% v v
-1
 
i
PrOH. 
Reactions were shaken at 250 r.p.m. at the selected 
temperatures for the corresponding time. Once finished, the 
crude reactions were extracted with EtOAc (3 x 5 mL), the 
organic layers were combined, dried onto Na2SO4 and the 
solvent was removed under reduced pressure. Samples 
obtained were analyzed by GC and/or HPLC in order to 
determine the conversions and the enantiomeric excesses of 
the final products. 
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